Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis

Cited by (289)

Items 101–200 of 289

1. Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
   Per Nived, Tore Saxne, Pierre Geborek, Thomas Mandl, Lillemor Skattum, Meliha Crnkic Kapetanovic · 2018 · BMC Rheumatology
2. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
   Amit Saxena, Allison Guttmann, Mala Masson, Mimi Kim, Rebecca H. Haberman, Rochelle Castillo, José U. Scher, Kristina Deonaraine, Alexis Engel, Michael H Belmont et al. · 2021 · The Lancet Rheumatology
3. Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses
   Alexander Domnich, Ilaria Manini, Giovanna Elisa Calabrò, Chiara de Waure, Emanuele Montomoli · 2019 · Vaccines
4. Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications
   John E. McKinnon, Kathleen Maksimowicz‐McKinnon · 2015 · Translational research
5. Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
   Kiyoshi Migita, Yukihiro Akeda, Manabu Akazawa, Shigeto Tohma, Fuminori Hirano, Haruko Ideguchi, Ryutaro Matsumura, Eiichi Suematsu, Tomoya Miyamura, Shunsuke Mori et al. · 2015 · Medicine
6. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients
   Daryl Ray Cheng, Rebecca Barton, Anthea Louise Greenway, Nigel W. Crawford · 2016 · Expert Review of Vaccines
7. Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis
   Mathilde Bahuaud, Constance Beaudouin-Bazire, Marine Husson, Anna Moltó, Odile Launay, Frédéric Batteux, Maxime Dougados · 2018 · Human Vaccines & Immunotherapeutics
8. Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
   Ioana Andreica, Arturo Blazquez‐Navarro, Jan Sokolar, Moritz Anft, Uta Kiltz, Stephanie Pfaender, Elena Vidal Blanco, Timm Henning Westhoff, Nina Babel, Ulrik Stervbo et al. · 2022 · RMD Open
9. Methotrexate in inflammatory bowel disease
   Turki AlAmeel, Eman Al Sulais, Tim Raine · 2022 · Saudi Journal of Gastroenterology
10. Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
    Martin Feuchtenberger, Magdolna Szilvia Kovacs, Anna Eder, Axel Philipp Nigg, Arne Schäfer · 2022 · Rheumatology International
11. Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status
    SL Rasmussen, Kurt Fuursted, KA Nielsen, NP Laurberg, M. Sørensen, Steen Kåre Fagerberg, Peter Derek Christian Leutscher, Claus Rasmussen · 2020 · Scandinavian Journal of Rheumatology
12. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic
    Ennio Giulio Favalli, Gabriella Maioli, Martina Biggioggero, Roberto Felice Caporali · 2021 · Expert Review of Clinical Immunology
13. Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors—Literature Review and Statement of Experts from Polish Dermatological Society
    Joanna Narbutt, Zbigniew Michał Żuber, Aleksandra Lesiak, Natalia Bień, Jacek Cezary Szepietowski · 2024 · Vaccines
14. Recapture and improved outcome of pegloticase response with methotrexate–A report of two cases and review of the literature
    Sarah Y. Bessen, Michael Y. Bessen, Christianne M. Yung · 2018 · Seminars in Arthritis and Rheumatism
15. Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis
    Maxime Auroux, Benjamin Laurent, Baptiste Coste, Emmanuel Massy, Alexandre Mercier, I. Durieu, Cyrille B. Confavreux, Jean‐Christophe Lega, Sabine Mainbourg, Fabienne Coury · 2022 · Joint Bone Spine
16. Safety of TNF-α inhibitors therapy in patients with rheumatoid arthritis: an umbrella review
    Ruijie Xiao, Peiyuan Tang, Jing Zhou, Weiyan Zheng, Yangbin Cao, Ying Zhu, Wenfeng Xiao, Han Tan, Ting Wen, Ahmed Abdirahman et al. · 2025 · EClinicalMedicine
17. Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case–control study (COVID-19VacRTX)
    Falk Schumacher, Nikola Mrdenovic, Dennis Scheicht, Jörn Pons‐Kühnemann, Christine Scheibelhut, Johannes Strunk · 2022 · Lara D. Veeken
18. Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
    Anwar Ibrahim Joudeh, Abdu Qaid Lutf, Salah Mahdi, Gui Tong Tran · 2023 · Vaccine
19. How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease
    J. Richards, S. Dowell, M. Quiñones, G. Kerr · 2015 · British medical journal
20. The impact of chemotherapy and hematopoietic stem cell transplantation on humoral immunity to vaccine-preventable diseases
    Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro · 2020 · Mediterranean Journal of Hematology and Infectious Diseases
21. Safety of treatments for primary Sjögren’s syndrome
    Jolien F. van Nimwegen, Rada V. Moerman, Nicole Sillevis Smitt-Kamminga, Elisabeth Brouwer, Hendrika Bootsma, Arjan Vissink · 2016 · Expert Opinion on Drug Safety
22. Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects
    Caitlyn L. Holmes, Chloe G. Peyton, Amy M. Bier, Tobias Z. Donlon, Fauzia Osman, Christie Michels Bartels, Miriam A. Shelef · 2019 · PLoS ONE
23. If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
    Iris M. Otani, Mark C. Ballow · 2024 · The Journal of Allergy and Clinical Immunology In Practice
24. The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy
    Ali Ekin, Belkıs Nihan Coşkun, Ediz Dalkılıç, Yavuz Pehlivan · 2022 · Irish Journal of Medical Science (1971 -)
25. Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: The Pneumovas Pilot 1 study
    Matthieu Groh, Xavier Puéchal, Benjamin Terrier, Claire Le Jeunne, Frédéric Batteux, Odile Launay · 2016 · Joint Bone Spine
26. The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
    Yu Bin Seo, Su‐Jin Moon, Chan Hong Jeon, Joon Young Song, Yoon‐Kyoung Sung, Su Jin Jeong, Ki Tae Kwon, Eu Suk Kim, Jae-Hoon Kim, Hyoun‐Ah Kim et al. · 2020 · Infection and Chemotherapy
27. B cell depletion in immune-mediated rheumatic diseases and coronavirus disease 2019 (COVID-19)
    Evgeny Lvovich Nasonov, Anastasia Sergeevna Avdeeva · 2021 · Rheumatology Science and Practice
28. Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature
    Dorra Ben Nessib, Alia Fazaa, S. Miladi, Meriem Sellami, Kmar Ouenniche, Leila Souabni, Salma Kassab, Salma Chekili, K. Ben Abdelghani, A. Laatar · 2020 · Therapies
29. The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
    Maysoon T. Al-Haideri, Reza Mannani, Roghayyeh Kaboli, Farshad Gharebakhshi, Shahram Darvishzadehdeldari, Safa Tahmasebi, Fatemeh Faramarzi, Juan Carlos Cotrina-Aliaga, Sahar Khorasani, Mina Alimohammadi et al. · 2023 · Transplant Immunology
30. Immunization in patients with inflammatory rheumatic diseases
    Κonstantinos Thomas, Dimitrios Vassilopoulos · 2016 · Best Practice & Research Clinical Rheumatology
31. Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
    Puja Mehta, Emilie Sanchez, Elena Moraitis, Nicky Longley, Dennis William Lendrem, Ian Giles, Rachel Clare Chambers, Coziana Ciurtin, John Dudley Isaacs · 2020 · The Lancet Rheumatology
32. Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity
    Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, Ana Cristina de Medeiros Ribeiro, Emily Figueiredo Neves Yuki, Carla Gonçalves Schahin Saad, Clóvis A. Silva, Léonard de Vinci Kanda Kupa, Lorena Elizabeth Betancourt Villamarín, Victor Adriano de Oliveira Martins et al. · 2022 · Clinical Rheumatology
33. Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs
    Antonio Cristaudo, Dario Graceffa, Fulvia Pimpinelli, Francesca Sperati, G. Spoletini, Claudio Bonifati, Raul Pellini, Viviana Lora, Martina Pontone, Ornella Di Bella et al. · 2021 · Journal of the European Academy of Dermatology and Venereology
34. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients
    Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto et al. · 2022 · Scientific Reports
35. Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Federica Filippini, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Cesare Tomasi, Franco Franceschini, Arnaldo Caruso, Ilaria Cavazzana, Cinzia Giagulli · 2023 · BMC Medicine
36. Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies
    Samuel D. Klebanoff, Lauren B. Rodda, Chihiro Morishima, Mark H. Wener, Yevgeniy Yuzefpolskiy, Estelle Bettelli, Jane Hoyt Buckner, Cate Speake, Marion Pepper, Daniel Campbell · 2023 · JCI Insight
37. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
    Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg, Anders A Bengtsson, Monika Hansson, Sophie Ohlsson, Elisa Pin, Lars Klareskog et al. · 2023 · Vaccine
38. Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis
    Shunsuke Mori, Yukitaka Ueki, Naruhiko Ishiwada · 2022 · Modern Rheumatology
39. Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
    Huiqiong Zeng, Hanjiang Liu, Zhi Liu, Xiakai Zhou, Xiaoping Lu, Zhenbo Yan, Yan Zhou, Liping Dai, Yashuo Chen, Tingting Yang et al. · 2022 · Human Vaccines & Immunotherapeutics
40. Riesgo de infección asociado a los inhibidores de las quinasas Janus (JAK) y las terapias biológicas en enfermedad inflamatoria intestinal y artritis reumatoide. Estrategias de prevención
    Xavier Calvet, Daniel Carpio, Iago Rodríguez–Lago, Rosario García‐Vicuña, Manuel Barreiro‐de Acosta, Xavier Juanola, Mariam Aguas, Concepción Castillo, Jordi Gratacós A · 2021 · Gastroenterología y Hepatología
41. Reducing Missed Opportunities for Influenza Vaccination in Patients with Rheumatoid Arthritis: Evaluation of a Multisystem Intervention
    Rachel Broderick, Iazsmin Bauer Ventura, Sunoz Soroosh, Lourdes Franco, Jon T. Giles · 2018 · The Journal of Rheumatology
42. Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR)
    Christophe Richez, Jacques Morel, Divi Cornec, C. Daïen, Philippe Goupille, Estibaliz Lazaro, Thierry Lequerré, Gaëtane Nocturne, Victor de Lédinghen, Benoît Le Goff et al. · 2019 · Joint Bone Spine
43. Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review
    Alice J. Tan, Jenna L. Streicher, Joseph Frank Merola, Megan H. Noe · 2021 · Dermatology Online Journal
44. Vaccination Recommendations for Adults With Autoimmune Inflammatory Rheumatic Diseases in Latin America
    Claiton Viegas Brenol, Valderílio Feijó Azevedo, Pablo Bonvehí, Paola Ximena Coral-Alvarado, Julio Granados, Roberto Muñoz-Louis, Carlos Pineda, Carla Vizzotti · 2017 · JCR Journal of Clinical Rheumatology
45. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
    Andrea Picchianti Diamanti, Maria Manuela Rosado, Emanuele Nicastri, Giorgio Sesti, Claudio Pioli, Bruno Laganà · 2021 · Frontiers in Immunology
46. SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
    Alexandra Dopfer‐Jablonka, Sandra Steffens, Frank Müller, Marie Mikuteit, Jacqueline Niewolik, Anne Cossmann, Metodi V. Stankov, Georg M. N. Behrens, Eva Hummers, Gloria Heesen et al. · 2022 · BMC Infectious Diseases
47. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis
    Vikramraj K. Jain, Nandhini Bhashini, Karthik Balajee Laksham, Sujatha Sistla, Subhash Chandra Parija, Vir Singh Negi · 2017 · The Indian Journal of Medical Research
48. Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis
    Pedro Martínez‐Fleta, Esther F. Vicente‐Rabaneda, Ana Triguero‐Martínez, Emilia Roy‐Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria García Montes, Noelia García-Castañeda et al. · 2024 · npj Vaccines
49. Uptake and safety of pneumococcal vaccination in adults with immune-mediated inflammatory diseases: a UK wide observational study
    Georgina Nakafero, Matthew J. Grainge, Tim R Card, Christian David Mallen, Jonathan S. Nguyen‐Van‐Tam, Abhishek Abhishek · 2024 · Lara D. Veeken
50. Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
    Yiqing Zheng, Hejun Li, Ling Chen, Shunping Lin · 2022 · Scientific Reports
51. Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis
    Johanna Nagel, Goran G. Jonsson, J-Å Nilsson, Chanchai Manuswin, Martin Englund, Tore Saxne, Meliha Crnkic Kapetanovic · 2022 · Vaccine
52. Safety of off-label biologicals in systemic lupus erythematosus
    Martin Aringer, Josef S Smolen · 2014 · Expert Opinion on Drug Safety
53. Pneumococcal Polysaccharide Vaccines
    John D. Grabenstein, Daniel M. Musher · 2017 · Elsevier eBooks
54. Persistence of antibodies to pneumococcal conjugate vaccine compared to polysaccharide vaccine in patients with Crohn’s disease – one year follow up
    Bjørn Kantsø, Sofie Ingdam Halkjær, Ole Østergaard Thomsen, Erika Bélard, Ida B. Gottschalck, Charlotte Sværke Jørgensen, Karen Angeliki Krogfelt, Hans‐Christian Slotved, Helene Andrea Sinclair Ingels, Andreas Munk Petersen · 2019 · Scandinavian Journal of Infectious Diseases
55. Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy
    Koichi Sugihara, Risa Wakiya, Hiromi Shimada, Tomohiro Kameda, S. Nakashima, Mikiya Kato, T. Miyagi, Mao Mizusaki, Rina Mino, Yumi Nomura et al. · 2022 · Internal Medicine
56. Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
    Dario Graceffa, Francesca Sperati, Claudio Bonifati, Gabriele Spoletini, Viviana Lora, Fulvia Pimpinelli, Martina Pontone, Raul Pellini, Ornella Di Bella, Aldo Morrone et al. · 2022 · Frontiers in Medicine
57. Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review
    Mario Rivera‐Izquierdo, María del Carmen Valero-Ubierna, Pelayo Nieto-Gómez, María Dolores Martínez-Bellón, Nicolás Francisco Fernández‐Martínez, José Luis Barranco Quintana · 2020 · Expert Review of Vaccines
58. Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients
    Evelina Elmér, Per Nived, Åsa Pettersson, Lillemor Skattum, Thomas Hellmark, Meliha Crnkic Kapetanovic, Åsa C. M. Johansson · 2022 · Journal of Immunology Research
59. Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
    Leher Gumber, Nancy E. Gomez, Georgina V. Hopkins, Davis Tucis, Laura G. Bartlett, Kieran Ayling, Kavita Vedhara, Graham Steers, Mithun Chakravorty, Megan Rutter et al. · 2022 · Lara D. Veeken
60. Aktualisierte Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit entzündlich-rheumatischen Erkrankungen im Rahmen der SARS-CoV‑2/COVID‑19-Pandemie einschließlich Empfehlungen zur COVID‑19-Impfung
    Christof Specker, Peer Malte Aries, Jürgen Braun, Gerd Rüdiger Burmester, Rebecca Fischer‐Betz, Rebecca Hasseli, Julia Ulrike Holle, Bimba F. Hoyer, Christof Iking‐Konert, Andreas Krause et al. · 2021 · Zeitschrift für Rheumatologie
61. Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
    Dinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, Alison M.E. Whitelegg · 2022 · Cellular Immunology
62. Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity
    Nora Pernaa, Salla Keskitalo, Iftekhar Mahmud Chowdhury, Antti E.T. Nissinen, Virpi Glumoff, Riikka Keski‐Filppula, Juhani M. Junttila, Kari K. Eklund, Wenny Santaniemi, Sanna M. Siitonen et al. · 2022 · Frontiers in Immunology
63. Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
    Jacques Morel, Emmanuelle Dernis, Christian Hubert Roux, Christophe Richez, Olivier Brocq, Bruno Fautrel, Carine Salliot, Olivier Vittecoq, Xavier Mariette A, Frédéric Lioté et al. · 2025 · The Lancet Rheumatology
64. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
    Jakub Wroński, Marzena Ciechomska, Ewa Kuca‐Warnawin · 2023 · Biomedicine & Pharmacotherapy
65. Safety of Recombinant Zoster Vaccine in Rheumatology Patients
    Syed Raza, Saurav Acharya, Gabrielle Howard, Debendra Pattanaik · 2022 · Southern Medical Journal
66. Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
    Abhishek Abhishek, R.J. Boyton, Áine McKnight, Laura C. Coates, James Bluett, Vicki S Barber, Lucy Cureton, Anne Francis, D. E. Appelbe, Lucy Eldridge et al. · 2022 · BMJ Open
67. COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour
    Christian Gytz Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen, Lars Erik Bartels, Marie‐Louise From Hermansen, Anders Dahl Johannsen, Clara Elbæk Mistegaard, Susan Mikkelsen, Signe Risbøl Vils, Christian Erikstrup et al. · 2022 · Modern Rheumatology
68. INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Г. М. Тарасова, Boris Sergeyevich Belov, Daria V. Bukhanova, M. Cherkasova, Sergey K. Solovyev, Elena Aleksandrovna Aseeva, Tatiana Magomedalievna Reshetnyak, Т. В. Попкова · 2018 · Rheumatology Science and Practice
69. SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response
    Frank Verhoeven, Quentin Lepiller, Sophie Hecquet, Clément Prati, Daniel Wendling · 2021 · Joint Bone Spine
70. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies
    Xavier Calvet, Daniel Carpio, Iago Rodríguez–Lago, Rosario García‐Vicuña, Manuel Barreiro‐de Acosta, Xavier Juanola, Mariam Aguas, Concepción Castillo, Jordi Gratacós A · 2021 · Gastroenterología y Hepatología (English Edition)
71. Approach to vaccination in systemic lupus erythematosus on biological treatment
    Reşit Yıldırım, Tatiana Oliveira, David Alan Isenberg · 2023 · Annals of the Rheumatic Diseases
72. Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents
    Meliha Crnkic Kapetanovic · 2014 · The Journal of Rheumatology
73. A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany
    Rebecca Hasseli, Alexander Pfeil, Andreas Krause, Hendrik Schulze‐Koops, Ulf Müller‐Ladner, Christof Specker, for the COVID-19 Task Force of the German Society for Rheumatology (DGRh), Bimba F. Hoyer, Hanns‐Martin Lorenz, Anne C. Regierer et al. · 2021 · Rheumatology International
74. Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
    Ting Zhao, Jiayan Shen, Youyang Zhu, Xiaofang Tian, Guangfen Wen, Yuanyuan Wei, Bonan Xu, Chenyang Fu, Zhaohu Xie, Yujiang Xi et al. · 2022 · Frontiers in Public Health
75. Between COVID-19 severity and its prevention – what should rheumatologists be aware of?
    Joanna Samanta Makowska, Filip Styrzyński · 2021 · Reumatologia/Rheumatology
76. Pneumococcal and influenza vaccination coverage and impact on COVID-19 infection severity in patients with inflammatory rheumatic diseases: A French National Healthcare Database analysis
    Maxime Auroux, Thibaut Fabacher, Erik Sauleau, Laurent Arnaud, Fabienne Coury · 2025 · Vaccine
77. Vaccination Update and Specific Concerns for RA
    Mariana Urquiaga, Kevin L. Winthrop, Jeffrey R. Curtis · 2025 · Current Rheumatology Reports
78. Should we stop methotrexate or not for vaccination?
    Patrick Durez, Bernard G Combe · 2023 · RMD Open
79. Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal
    Maria Francisca Moraes‐Fontes, Ana Margarida Antunes, Heidi Gruner, Nuno Riso · 2016 · International Journal of Rheumatology
80. COVID-19: a primer for the rheumatologist: management of patients and care settings
    Cassandra M. Calabrese, Bethany Lehman · 2020 · Current Opinion in Rheumatology
81. Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
    Jérémie Sellam, Jacques Morel, Anne Tournadre, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle‐Pensec, Philippe Dieudé, Philippe Goupille, D. Jullien, Nicolas Kluger et al. · 2021 · Joint Bone Spine
82. Infection prevention and vaccination in the rheumatic diseases
    Jacques Morel · 2023 · Joint Bone Spine
83. COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases
    José M. Serra López-Matencio, Esther F. Vicente‐Rabaneda, Estefanía Alañón, AINHOA ARANGUREN OYARZABAL, Pedro Martínez‐Fleta, Santos Castañeda · 2023 · Vaccines
84. Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024
    Mario Rivera‐Izquierdo, Arturo Morales-Portillo, Inmaculada Guerrero-Fernández de Alba, Nicolás Francisco Fernández‐Martínez, Joan Antoni Schoenenberger-Arnaiz, José Luis Barranco Quintana, Carmen Valero-Ubierna · 2024 · Expert Review of Vaccines
85. Vaccinations in Patients with Rheumatic Disease
    Cassandra M. Calabrese · 2021 · Medical Clinics of North America
86. Prevention ofStreptococcus pneumoniae(pneumococcal) infections in adults
    Endre Ludwig, Zsófia Mészner · 2014 · Orvosi Hetilap
87. Fighting Malnutrition: An Evaluation of Brazilian Food and Nutrition Programs
    Philip Musgrove · 1989
88. Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review
    David Klank, Martin Franz Hoffmann, Bernd Claus, Florian Zinke, Raoul Bergner, Peter Paschka · 2021 · HemaSphere
89. Humoral and T Cell Response to SARS‐CoV ‐2 Vaccination in Patients With Rheumatoid Arthritis
    C. A. Isnardi, Margarita Landi, Leonel Cruces, Pablo Maid, Claudia Calle Montoro, María Agustina Alfaro, Brian Manases Roldán, Andrea B. Gómez Vara, Pamela Giorgis, Roberto A. Ezquer et al. · 2023 · Arthritis Care & Research
90. Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
    C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, Chih‐Wei Tseng, Carlos Enrique Toro Gutiérrez, Ai Lyn Tan, Arvind Nune, Esha Kadam, Masataka Kuwana, Jessica Alice Day et al. · 2024 · Rheumatology International
91. Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India
    Vikramraj K. Jain, Kavitha Mohanasundaram, Sharath Kumar, Chengappa G. Kavadichanda, Rajendra Varaprasad Irlapati, Neha Mishra, Balaji Veeraraghavan, Subramanian Swaminathan, Devaki Lakshminarayanan, S. Baghel et al. · 2024 · Indian Journal of Rheumatology
92. Vaccination in rheumatology: Evolution of views on the problem
    Boris Sergeyevich Belov, M. S. Sergeeva, Г. М. Тарасова, Daria V. Bukhanova · 2017 · Terapevticheskii arkhiv
93. Respuesta serológica en pacientes con enfermedades inflamatorias autoinmunes tras la vacunación de la gripe: resultados del estudio RIER
    Patricia Richi, María Dolores Martín, Cristina Andreu Vázquez, Ana Jiménez-Diaz, Martina Steiner, Santiago Muñoz‐Fernández · 2020 · Medicina Clínica
94. Papillomavirus humain et lupus érythémateux systémique
    Emmanuelle David, Alexandre Bélot, Jean‐Christophe Lega, I. Durieu, Christine Rousset‐Jablonski · 2021 · La Revue de Médecine Interne
95. A Review of the Efficacy of Influenza Vaccination in Autoimmune Disease Patients
    Mandi Abdelahad, Elizabeth Ta, Marc M Kesselman, Michelle Demory Beckler · 2021 · Cureus
96. Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study
    Alan Morrison, Melissa E. Stauffer, Anna S. Kaufman · 2021 · Open Access Rheumatology Research and Reviews
97. Humoral Response of Patients With Autoimmune Rheumatic Disease to BNT162b2 Vaccine: A Retrospective Comparative Study
    Omar Suhail Alsaed, Samar Al Emadi, Eman Satti, Bassam Muthanna, Safna Farsana Akkam Veettil, Hadeel Ashour, Prem Chandra, Einas Al‐Kuwari, Peter Valentine Coyle · 2022 · Cureus
98. Vaccinations in Rheumatoid Arthritis
    Eitan Giat, Merav Lidar · 2015
99. Influenza Vaccine Type-Dependent Antibody Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
    Sofie Larsen Rasmussen, Prabhat Kumar, Ramona Trebbien, Peter Derek Christian Leutscher, Claus Rasmussen · 2023 · European Journal of Rheumatology
100. Implications of potential clinically relevant interactions between COVID‐19 vaccines and concomitant medications
     Osama Ahmed Badary · 2023 · Reviews in Medical Virology